Nagai N - Search Results

1

Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.

Kaneyasu Y, Nagai N, Nagata Y, Hashimoto Y, Yuki S, Murakami Y, Kenjo M, Kakizawa H, Toyota N, Fujiwara H, Kudo Y, Ito K. Kaneyasu Y, et al. Among authors: nagai n. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):369-77. doi: 10.1016/j.ijrobp.2009.02.081. Int J Radiat Oncol Biol Phys. 2009. PMID: 19735865

2

Distribution of platinum in the female genital tract and efficacy of radiotherapy combined with transcatheter arterial infusion of cisplatin for locally advanced stage IIIb carcinoma of the uterine cervix.

Nagai N, Kaneyasu Y, Komatsu M, Shiroyama Y, Oshita T, Watasaki S, Ito K. Nagai N, et al. Oncol Rep. 2009 Mar;21(3):585-91. Oncol Rep. 2009. PMID: 19212615 Clinical Trial.

3

Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: a prospective follow-up study.

Nagai N, Oshita T, Murakami J, Shigemasa K, Hirokawa Y, Ohama K. Nagai N, et al. Oncol Rep. 2001 Jan-Feb;8(1):119-25. doi: 10.3892/or.8.1.119. Oncol Rep. 2001. PMID: 11115582 Clinical Trial.

4

Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.

Yunokawa M, Tanimoto K, Nakamura H, Nagai N, Kudo Y, Kawamoto T, Kato Y, Hiyama E, Hiyama K, Nishiyama M. Yunokawa M, et al. Among authors: nagai n. Oncol Rep. 2007 Apr;17(4):871-8. Oncol Rep. 2007. PMID: 17342330

5

Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers.

Komatsu M, Hiyama K, Tanimoto K, Yunokawa M, Otani K, Ohtaki M, Hiyama E, Kigawa J, Ohwada M, Suzuki M, Nagai N, Kudo Y, Nishiyama M. Komatsu M, et al. Among authors: nagai n. Mol Cancer Ther. 2006 Mar;5(3):767-75. doi: 10.1158/1535-7163.MCT-05-0408. Mol Cancer Ther. 2006. PMID: 16546992

6

Expression of tumor-associated differentially expressed Gene-14 (TADG-14/KLK8) and its protein hK8 in uterine endometria and endometrial carcinomas.

Jin H, Nagai N, Shigemasa K, Gu L, Tanimoto H, Yunokawa M, Ohama K, Kudo Y, O'Brien TJ. Jin H, et al. Among authors: nagai n. Tumour Biol. 2006;27(5):274-82. doi: 10.1159/000094741. Epub 2006 Jul 28. Tumour Biol. 2006. PMID: 16888409

7

Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report.

Nagai N, Hirata E, Kusuda T, Mukai K, Arihiro K, Ohama K. Nagai N, et al. Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1187-90. doi: 10.1111/j.1525-1438.2005.00186.x. Int J Gynecol Cancer. 2005. PMID: 16343210 Free article.

8

Tumor dihydropyrimidine dehydrogenase activity in advanced cervical carcinoma.

Nagai N, Shiroyama Y, Oshita T, Mukai K, Shigemasa K, Fujii T, Katsube Y, Matsubayashi S, Murakami T, Ohama K. Nagai N, et al. Oncol Rep. 2002 Sep-Oct;9(5):1033-40. Oncol Rep. 2002. PMID: 12168069

9

Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy.

Nagai N, Tian X, Mukai K, Hirata E, Kusuda T, Shiroyama Y, Shigemasa K, Ohama K. Nagai N, et al. Int J Mol Med. 2003 Nov;12(5):709-14. Int J Mol Med. 2003. PMID: 14532998 Clinical Trial.

10

Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas.

Tian X, Shigemasa K, Hirata E, Gu L, Uebaba Y, Nagai N, O'Brien TJ, Ohama K. Tian X, et al. Among authors: nagai n. Oncol Rep. 2004 Nov;12(5):1001-6. Oncol Rep. 2004. PMID: 15492784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,073 results

Search Page

Filters